Eikon Therapeutics, INC. (EIKN) — 10-K Filings
All 10-K filings from Eikon Therapeutics, INC.. Browse 1 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (1)
-
Eikon Pushes Oncology Pipeline, Faces Profitability Hurdles
— Mar 30, 2026 Risk: high
Eikon Therapeutics, Inc. (EIKN) is a late clinical-stage biopharmaceutical company focused on oncology, led by experienced drug developers Dr. Roger M. Perlmutt
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX